SK pharmteco and AaviGen Announce Strategic Partnership to Manufacture AaviGen’s Lead Gene Therapy Product for Heart Failure
FOR IMMEDIATE RELEASE PARIS, France and HEIDELBERG, Germany (October 2, 2024) – SK pharmteco, a global contract development and manufacturing